-
A Cross-Sectional Analysis of Early Access Programs in NICE Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Natural Language Processing Solution (REALLI) to Evaluate the Limitations of the French National Health Insurance Database (SNDS): Example of HER2+ Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Clinical Humanistic and Economic Burden Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM -
Out-of-Pocket Expenditures of Families Affected by Epidermolysis Bullosa in Europe
Sep 9, 2025, 16:22 PM -
Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy
Sep 9, 2025, 16:22 PM -
Lessons From the NHS AI Awards: Experience of Evaluating AI Tools in Real-World Environments
Sep 9, 2025, 16:22 PM -
A Case Study: How England Implemented Its First Population Health Agreement
Sep 9, 2025, 16:22 PM -
How the EU JCA Could Interface With Regional Pricing Alliances (BeNeLuxA, Nordic Forum, Valletta Group) and EU-Level Procurement Under the Critical Medicines Act
Sep 9, 2025, 16:22 PM -
Small Molecules vs. Biologics Patterns of Indication Expansion and the Potential Impact of Medicare Price Negotiation
Sep 9, 2025, 16:22 PM -
Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5
Sep 9, 2025, 16:22 PM -
Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Human Metapneumovirus (hMPV): Systematic Literature Review of Economic and Humanistic Disease Burden in Adults
Sep 9, 2025, 16:22 PM -
A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data
Sep 9, 2025, 16:22 PM -
Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?
Sep 9, 2025, 16:22 PM -
Characterizing Medicines Reimbursed Under Managed Access Protocols in Ireland (2006-2025)
Sep 9, 2025, 16:22 PM -
Surviving but Not Earning? Long-term Income Trajectories in Working-Age mIDH Glioma Patients: Stratification by Radiotherapy/Chemotherapy Exposure
Sep 9, 2025, 16:22 PM -
Adoption of AI Clinical Decision Support Systems in Primary Care: An Evaluation of Physician Acceptance
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices
Sep 9, 2025, 16:22 PM
